Navigation Links
BioMarin Announces Third Quarter 2009 Financial Results
Date:10/28/2009

culated in accordance with GAAP, but excludes non-cash stock compensation expense, certain nonrecurring material items and the tax effect of the adjustments.

Non-GAAP net income in the third quarter of 2009 and the third quarter of 2008 excluded (1) stock compensation expense of $8.9 million in the third quarter of 2009 and $7.4 million in the third quarter of 2008; (2) upfront license fees paid of $1.4 million in the third quarter of 2008; (3) Kuvan approval milestones received of $1.5 million in the third quarter of 2008 and (4) income tax effect of $0.1 million in the third quarter of 2008. Non-GAAP net income in the nine months ended September 30, 2009 and the nine months ended September 30, 2008 excluded (1) stock compensation expense of $25.7 million in the nine months ended September 30, 2009 and $17.8 million in the nine months ended September 30, 2008; (2) upfront license fees paid of $8.8 million in the nine months ended September 30, 2009 and $1.4 million in the nine months ended September 30, 2008; (3) impairment charges of $5.9 million in the nine months ended September 30, 2009; (4) Kuvan approval milestones received of $1.5 million in the nine months ended September 30, 2008; (5) initial Aldurazyme transfer revenue of $2.3 million in the nine months ended September 30, 2008; (6) net gain on the sale of equity investments of $1.6 million in the nine months ended September 30, 2009 and (7) income tax effect of $0.3 million and $0.2 million in the nine months ended September 30, 2009 and 2008, respectively.

Anticipated non-GAAP net income for the year ended December 31, 2009 and actual results for the year ended December 31, 2008 exclude (1) stock compensation expense of $35.0 million anticipated for 2009 and $25.3 million for 2008; (2) upfront license fees of $8.8 million associated with the La Jolla Pharmaceutical Corporation transaction in 2009 and $1.4 million associated with the Summit transaction in 2008; (3) impairment ch
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. BioMarin to Present at the Oppenheimer Healthcare Conference
2. BioMarin Acquires Huxley Pharmaceuticals, Inc.
3. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
4. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
5. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
6. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
7. BioMarin Announces FDA Approval for Kuvan
8. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
9. Rigel Announces Presentations at Two Investor Conferences
10. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
11. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... PROSPECT, Ill. , June 18, 2013 /PRNewswire-iReach/ ... of its new X3130 Appliance Inlet Module. The ... circuit breaker , combines a C14 appliance inlet ... one compact package.  This three-in-one device allows design ... their designs - cutting installation time by 66 ...
(Date:6/18/2013)... Mass. , June 18, 2013 ... the company was named Overall Performance Leader in Imaging ... Equipment & Infrastructure report. Philips also received Best in ... its imaging products: Ingenuity Core 128 Computed Tomography ... ultrasound and PageWriter TC70 cardiograph. The annual Best in ...
(Date:6/18/2013)... 18, 2013 Unilife Corporation ("Unilife" or "Company") ... and manufacturer of injectable drug delivery systems, today announced ... www.unilife.com . The new site includes additional products, videos, ... on a regular basis. Mr. Alan ... emerging global leader for injectable drug delivery systems, we ...
Breaking Medicine Technology:Three-in-One X3130 Appliance Inlet Module 2Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS 2Unilife Launches New Corporate Website 2
... Inc. (Nasdaq: MSHL ), an oncology company ... cancer metabolism, announced today that it has filed a ... Exchange Commission for a rights offering to existing stockholders ... stock. The Company will announce further details regarding the ...
... Feb. 21, 2012  Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... will present a company overview at Citi,s 2012 Global Health ... ET at the Waldorf Astoria in New York City. ... available on the "Investors & Media" section of the Company,s ...
Cached Medicine Technology:Marshall Edwards Announces Rights Offering to Stockholders 2Marshall Edwards Announces Rights Offering to Stockholders 3
(Date:6/19/2013)... CA (PRWEB) June 19, 2013 When looking ... are specifically trying to figure out how to lose belly ... such as the underarms and thighs. Unnecessary and excess fat ... and exercise alone; therefore, Diet Doc created their hCG ... hCG diets combine powerful weight loss aids with nutritious ...
(Date:6/19/2013)... Blueforce Development Corporation, a leader ... today announced it has been awarded United States ... technology. The award coincides with a highly ... strategic partnerships. , Blueforce Development creates and ... (M2M) software products that support the rapid formation ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Walkingspree, a ... today announced the launch of its new Facebook App. ... motivate and inspire participants to reach their program fitness ... platform , Walkingspree clients are given more tools to ... member profile. , Corporate clients may choose whether or ...
(Date:6/19/2013)... Francisco, CA (PRWEB) June 19, 2013 The ... sized tents is because users can place a 4x8 flood ... clearance boundary space to work around. In addition, Gorilla ... tents. Because they are the tallest, thickest and strongest grow ... new bar for grow tent standards. , Gorilla ...
(Date:6/19/2013)... 2013 The website HealthNewsWires.com has recently ... its harmful effects and tips to manage and prevent ... from HealthNewsWires.com, the author defines insulin resistance ... remove and process glucose from the bloodstream. Glucose, ... all cells, organs and systems of the body for ...
Breaking Medicine News(10 mins):Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce A New Four Phase Program that Allows Patients to Lose Belly Fat, Thigh Fat and Underarm Fat Easily 2Health News:Blueforce Awarded Patent for Decentralized Sensor Fusion 2Health News:Walkingspree’s New Facebook Connectivity Boosts Accountability and Engagement 2Health News:Stealth Grow Tent Brand’s Popularity Rises 2Health News:Effects of Insulin Resistance and How to Increase Insulin Sensitivity Published in New Video by Health News Wire 2
... and PHILADELPHIA, Nov. 14 ,GlaxoSmithKline announced today that ... for Avandia(R) (rosiglitazone maleate), based on an extensive,and ... data on Avandia, the,most widely studied oral anti-diabetic ... been revised to add the FDA,s conclusion,that, while ...
... Conjunction with Inaugural Gala, NORTH ADAMS, Mass., Nov. ... Safety Foundation today announced that it will hold,its first ... Massachusetts. The Institute, established by NPSF in May 2007, ... calls to action for,the field of patient safety. Its ...
... research suggests , WEDNESDAY, Nov. 14 (HealthDay News) -- Providing ... a number of weeks can help cut their nicotine addiction, ... at the University of California, San Francisco, and San ... puffed on their usual brand for the first week of ...
... has been published in the World Journal of Gastroenterology ... was the first case of gastric carcinosarcoma obtained in ... admitted by Dr. Tomislav Randjelovic as surgeon and Dr. ... Dr. Randjelovic and his team; the anatomical and patoanatomical ...
... MediNotes Corporation, a,leading provider of electronic medical record ... announced that MediNotes e reached,another technological benchmark by ... HL7 as the industry standard for,connectivity. MediNotes, ability ... in the amount of PMS it interfaced with ...
... and PulseOx 6100(TM) to be launched at MEDICA in ... Inc. (OTC,Bulletin Board: SPOM), a leading developer of biosensor ... announced that,the PulseOx 6000(TM) and PulseOx 6100(TM), two new ... the 39th MEDICA World Forum for,Medicine in Dusseldorf, Germany ...
Cached Medicine News:Health News:GSK Revises US Labeling for Avandia(R) 2Health News:GSK Revises US Labeling for Avandia(R) 3Health News:GSK Revises US Labeling for Avandia(R) 4Health News:Lucian Leape Institute Announces First Roundtable 2Health News:Lucian Leape Institute Announces First Roundtable 3Health News:Nicotine-Reduced Cigarettes Could Boost Quitting 2Health News:MediNotes EMR Now Interfaces With 76 Practice Management Systems, Allowing More Medical Practices to Replace Their Patients' Aging Paper Medical Records 2Health News:SPO Medical Unveils New Oximetry Devices for European Markets 2Health News:SPO Medical Unveils New Oximetry Devices for European Markets 3
... display of corneal layers: endothelium, ... epithelial layers. Accurate analysis of ... keratocytes, nerve fibres, basal & ... surgery and pathology: optical pachymetry, ...
The Ahmed Glaucoma Valve has been successfully demonstrated to work in all types of glaucoma cases, particularly neovascular, congenital and uvietic glaucoma....
Ahmed Glaucoma Valve with Pars Plana Clip....
Ahmed Glaucoma Valve Flexible Plate ....
Medicine Products: